Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 1 of 1 for:    NCT02524951
Previous Study | Return to List | Next Study

Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02524951
Recruitment Status : Terminated (lack of interest by sponsor)
First Posted : August 17, 2015
Last Update Posted : May 18, 2018
DepYmed Inc.
Information provided by (Responsible Party):
Daniel Budman, Northwell Health

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2017
Actual Study Completion Date : May 14, 2018